Testing effectiveness (Phase 2)Study completedNCT00003110What this trial is testingBleomycin in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Case Comprehensive Cancer Center 5
Early research (Phase 1)Active Not RecruitingNCT03479268What this trial is testingPevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin LymphomaWho this might be right forB-Cell Prolymphocytic LeukemiaRecurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell Lymphoma+15 more City of Hope Medical Center 18
Testing effectiveness (Phase 2)UnknownNCT01016990What this trial is testingValproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphoma Auxilio Mutuo Cancer Center 52
Early research (Phase 1)Looking for participantsNCT05098613What this trial is testingPreliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL PatientsWho this might be right forNon-Hodgkin LymphomaB-cell Non-Hodgkin Lymphoma (B-NHL)Mantle Cell Lymphoma (MCL)+1 more University of Colorado, Denver 68
Testing effectiveness (Phase 2)Looking for participantsNCT03223610What this trial is testingVenetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell LymphomaWho this might be right forLymphomaNon-Hodgkin LymphomaDiffuse Large B-Cell Lymphoma+1 more National Cancer Institute (NCI) 155
Testing effectiveness (Phase 2)Ended earlyNCT01944943What this trial is testingPhase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forDiffuse Large B-cell LymphomaIndolent Non-hodgkin LymphomaPrimary Central Nervous System Lymphoma+1 more The Lymphoma Academic Research Organisation 31
Testing effectiveness (Phase 2)Study completedNCT00002697What this trial is testingCombination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05826535What this trial is testingStudy of Rondecabtagene Autoleucel in Aggressive Large B-Cell LymphomaWho this might be right forRelapsed Non-Hodgkin LymphomaRefractory Non-Hodgkin LymphomaNon-Hodgkin Lymphoma+1 more Lyell Immunopharma, Inc. 270
Very early researchStudy completedNCT02981914What this trial is testingPilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell TransplantationWho this might be right forClassical Hodgkin LymphomaB-cell Non-Hodgkin LymphomaAcute Myeloid Leukemia+1 more University of Chicago 12
Testing effectiveness (Phase 2)Study completedNCT00644371What this trial is testingAllogenic Stem Cell Transplantation (SCT) With Non-myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL)Who this might be right forNon-Hodgkin Lymphoma Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 20
Testing effectiveness (Phase 2)Ended earlyNCT03088709What this trial is testingHaploidentical Stem Cell Transplantation Using Post-Transplant CyclophosphamideWho this might be right forAcute Myeloid LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndrome+2 more Loyola University 5
Testing effectiveness (Phase 2)Looking for participantsNCT06526793What this trial is testingSurovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHLWho this might be right forB-cell Non-Hodgkin LymphomaFollicular Lymphoma (FL)Large B-Cell Lymphoma (LBCL) AstraZeneca 270
Testing effectiveness (Phase 2)Looking for participantsNCT07365306What this trial is testingEpcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell LymphomaWho this might be right forRecurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent High Grade B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Primary Mediastinal Large B-Cell Lymphoma+5 more City of Hope Medical Center
Not applicableEnded earlyNCT00005786What this trial is testingArsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or LeukemiaWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaProlymphocytic Leukemia+8 more National Cancer Institute (NCI) 25
Large-scale testing (Phase 3)UnknownNCT00003924What this trial is testingInterferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's LymphomaWho this might be right forLymphoma Lymphoma Study Association 360
Not applicableStudy completedNCT00003196What this trial is testingLow-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple MyelomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+33 more Fred Hutchinson Cancer Center 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT03505762What this trial is testingTailored Prednisone Reduction in Preventing Hyperglycemia in Participants With B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy TreatmentWho this might be right forB-Cell Non-Hodgkin Lymphoma Wake Forest University Health Sciences 80
Testing effectiveness (Phase 2)Looking for participantsNCT06486051What this trial is testingAtlacabtagene Autoleucel CAR T-cells for Adults With Relapsed Large B-cell LymphomaWho this might be right forLarge B-cell LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedPrimary Mediastinal Large B-cell Lymphoma (PMBCL)+1 more Malaghan Institute of Medical Research 60
Testing effectiveness (Phase 2)Looking for participantsNCT06321289What this trial is testingAllogeneic TRAC Locus-inserted CD19-targeting STAR T Cell Therapy in r/r B-NHLWho this might be right forNon-hodgkin Lymphoma,B Cell Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00577629What this trial is testingChemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins LymphomaWho this might be right forLymphoma, B-Cell Duke University 39